Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Momenta Pharmaceuticals Inc.

www.momentapharma.com

Latest From Momenta Pharmaceuticals Inc.

Momenta Shelves Adalimumab But Persists With Aflibercept

Having failed to find a commercial partner, Momenta has halted development on its adalimumab biosimilar. But it is continuing to work on biosimilar aflibercept in conjunction with partner Mylan.

Biosimilars Business Strategies

Samsung Bioepis Gets US Adalimumab Nod

Samsung Bioepis has become the first company to receive FDA approvals for biosimilars of all three first-generation anti-TNF biologics after gaining a nod for its Hadlima biosimilar adalimumab.

Biosimilars Regulation

Amphastar Will Receive $59.9m In Momenta/Sandoz Settlement

The small generics company has talked about using the cash windfall from the expected settlement to fund clinical trials and possibly M&A.

Deals Intellectual Property

Amphastar Poised To Receive $59.9m In Momenta/Sandoz Settlement

The small generic drug company has talked about using the cash windfall from the expected settlement to fund clinical trials and possibly M&A.

Deals Intellectual Property
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Mimeon Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Momenta Pharmaceuticals Inc.
  • Senior Management
  • Craig A Wheeler, Pres. & CEO
    Michelle Robertson, CFO
    Young T Kwon, PhD, CBO
    Santiago Arroyo, MD, PhD, SVP, Dev. & CMO
    Anthony Manning, CSO
  • Contact Info
  • Momenta Pharmaceuticals Inc.
    Phone: (617) 491-9700
    301 Binney St.
    Cambridge, MA 02142
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register